Vaishali Sanchorawala, MBBS

Professor, Medicine

Vaishali Sanchorawala
732 Harrison Ave

Biography

Expertise includes: AL amyloidosis – clinical trials, treatment; Stem cell transplantation; Myeloma.

Other Positions

  • Director, Amyloidosis Center, Boston University School of Medicine
  • Active Staff Hospital Privileges, Medicine, Boston Medical Center

Education

  • Seth G.S. Medical College, MBBS

Classes Taught

Publications

  • Published on 9/1/2017

    Salinaro F, Meier-Ewert HK, Miller EJ, Pandey S, Sanchorawala V, Berk JL, Seldin DC, Ruberg FL. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2017 Sep 01; 18(9):1057-1064. PMID: 27965280.

    Read at: PubMed
  • Published on 9/1/2017

    Batalini F, Econimo L, Quillen K, Sloan JM, Sarosiek S, Brauneis D, Havasi A, Stern L, Dember LM, Sanchorawala V. High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease. Biol Blood Marrow Transplant. 2017 Sep 01. PMID: 28865972.

    Read at: PubMed
  • Published on 8/29/2017

    Sanchorawala V, McCausland KL, White MK, Bayliss MS, Guthrie SD, Lo S, Skinner M. A longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time. Br J Haematol. 2017 Nov; 179(3):461-470. PMID: 28850697.

    Read at: PubMed
  • Published on 7/24/2017

    Arun M, Brauneis D, Doros G, Shelton AC, Sloan JM, Quillen K, Ruberg FL, Sanchorawala V, Varga C. The incidence of atrial fibrillation among patients with AL amyloidosis undergoing high-dose melphalan and stem cell transplantation: experience at a single institution. Bone Marrow Transplant. 2017 Sep; 52(9):1349-1351. PMID: 28737773.

    Read at: PubMed
  • Published on 7/11/2017

    Browning S, Quillen K, Sloan JM, Doros G, Sarosiek S, Sanchorawala V. Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation. Blood. 2017 Sep 14; 130(11):1383-1386. PMID: 28698204.

    Read at: PubMed
  • Published on 5/26/2017

    Sanchorawala V, Palladini G, Kukreti V, Zonder JA, Cohen AD, Seldin DC, Dispenzieri A, Jaccard A, Schönland SO, Berg D, Yang H, Gupta N, Hui AM, Comenzo RL, Merlini G. A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis. Blood. 2017 Aug 03; 130(5):597-605. PMID: 28550039.

    Read at: PubMed
  • Published on 4/10/2017

    Govender P, Keyes CM, Hankinson EA, O'Hara CJ, Sanchorawala V, Berk JL. Transbronchial biopsies safely diagnose amyloid lung disease. Amyloid. 2017 Mar; 24(1):37-41. PMID: 28393574.

    Read at: PubMed
  • Published on 4/1/2017

    Graham MS, Pudusseri A, Helgager J, Narendra DP, De Girolami U, Pinkus GS, Sanchorawala V, Miyawaki E. A Woman in Her 40s With Headache and New-Onset Seizures. JAMA Neurol. 2017 Apr 01; 74(4):476-480. PMID: 28241235.

    Read at: PubMed
  • Published on 3/24/2017

    Pulido V, Doros G, Berk JL, Sanchorawala V. The six-minute walk test in patients with AL amyloidosis: a single centre case series. Br J Haematol. 2017 May; 177(3):388-394. PMID: 28340285.

    Read at: PubMed
  • Published on 10/22/2016

    Uwumugambi NA, Sanchorawala V, Shelton AC, Stern L, Gordon CE. Bendamustine-Induced Nephrogenic Diabetes Insipidus in a Patient With AL Amyloidosis. Am J Kidney Dis. 2017 Feb; 69(2):317-319. PMID: 27780577.

    Read at: PubMed

View 102 more publications: View full profile at BUMC

View all profiles